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Appendix Figure S1 . (P phsA151-342 ) had no effect on thiosulfateinduced promoter activation, indicating the 10 bp inverted repeat is not the ThsR binding site. Removal of the first 18 bp direct repeat (dark blue) also had no effect on promoter activation. Deletion of the promoter through the predicted CRP site or mutagenesis of the CRP site diminished sensor output (P phsA182-342, P phsA342~CRP ; 25-fold to 4-fold), and deletion of the second 18 bp repeat abolished thiosulfate-induced signaling (P phsA219-342 Mutagenesis of either 6 bp inverted repeat in the second 18 bp element (P PhsA342~O1 , P PhsA342~O2 ) also resulted in loss of signaling, supporting this sequence as the likely operator site. Mutated sequences are indicated under the wild type promoter sequence. No truncations were identified that gave enhanced promoter response, therefore the entire intergenic region was used as the output promoter.
Appendix Figure S3 . Plasmid maps for inducible ThsSR production. Figure S4 . Shal_3129-induced activation of P phsA342. Closed circles represent the wild type and open squares the phospho-accepting null mutant (D57A).
Appendix Figure S5 . Optimization of protein expression using inducible promoters to give the highest dynamic for ThsSR. Data are shown for all aTc and IPTG conditions tested in the (A) absence of thiosulfate (0 mM), (B) presence of saturating thiosulfate (5 mM), and (C) the fold difference between the two (sfGFP fluorescence 5 mM/0 mM thiosulfate). 
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Appendix Figure S7 . Schild plot analysis of ThsSR tetrathionate inhibition. (A) An increase in k 1/2 of the sensor was observed at higher concentrations of tetrathionate, however maximal response could not be achieved in the presence of tetrathionate. Thiosulfate concentrations >10 mM were not used because of an additional lowsensitivity response of ThsSR that would complicate analysis. (B) Schild plot of doseresponse data. Slope of the Schild plot was not 1 indicating tetrathionate is not a competitive antagonist or that the system is not in equilibrium.
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Appendix Figure S8 . Glucose sensitivity of thiosulfate-induced activation of ThsSR at P phsA . The full-length promoter (P phsA342 ), a 5' truncated promoter removing the CRP site (P phsA182-342 ), and a promoter with CRP binding motif mutated (P phsA342CRP ) were tested in M9 minimal media with 0.4% glycerol or 0.4% glucose as the carbon source. White bars are in the absence of thiosulfate, black bars are in the presence of 5 mM thiosulfate, and red circles are the fold induction (sfGFP fluorescence 5 mM/0 mM). Appendix Figure S12 . Optimization of protein expression using inducible promoters to give the highest dynamic for TtrSR. Data are shown for all aTc and IPTG conditions tested in the (A) absence of tetrathionate (0 mM), (B) presence of saturating tetrathionate (1 mM), and (C) the fold difference between the two (fluorescence 1 mM/0 mM tetrathionate). 2) The ThsR and ThsS plasmids were then combined together and screened for optimal expression in E. coli Nissle 1917 (fold induction +/-5 mM thiosulfate is indicated). Combinations that had significant growth defects are indicated in grey with a *. 3) In the best construct, the promoter of the constitutive mCherry marker was increased to allow for selection of the biosensor from the normal microbial floral and the construct was tested in anaerobic growth conditions. The final constructs used for in vivo studies are shown at the bottom. Final Optimized for increased mCherry production and anaerobic growth Make library of SK and RR plasmids with varying strength constitutive promoters Screen library Increase mCherry production in best construct and test in anaerobic chamber
Appendix Figure S16 . Optimization of TtrSR for use in the mammalian gut. 1) A library of varying strength constitutive promoters from the Anderson promoter library (indicated by identity J231XX) and a designed synthetic RBS were incorporated upstream of TtrS and TtrR.
2) The TtrR and TtrS plasmids were then combined together and screened for optimal expression in E. coli Nissle 1917 (fold induction +/-1 mM tetrathionate is indicated). Combinations that had significant growth defects are indicated in grey with a *. 3) In the best construct, the promoter of the constitutive mCherry marker was increased to allow for selection of the biosensor from the normal microbial floral and the construct was tested in anaerobic growth conditions. This resulted in a significant decrease in sensor performance. Because the best construct from the initial screen was the weakest promoter, additional synthetic RBSs designed to be weaker were designed with this promoter and the strong mCherry promoter was incorporated into all RR plasmids. These plasmids were then combined and screened in anaerobic conditions. Although the best construct appears to be TtrR 09c and TtrS 14, the inactivating control plasmid (D55A) was not made in time for in vivo experiments. Therefore, the best available plasmid was used (indicated by a black box) which gave good dynamic range. The final constructs used for in vivo studies are shown at the bottom. Appendix Figure S18 . Plasmid maps for constitutive TtrSR production used in in vivo studies. 
